Detalhe da pesquisa
1.
The Establishment of Indicators of Thrombocytopenia in Patients Receiving Lenalidomide Therapy.
Gan To Kagaku Ryoho
; 42(13): 2447-50, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26809302
2.
[Analysis of factors influencing the occurrence of infusion reaction after initial treatment with rituximab].
Gan To Kagaku Ryoho
; 41(8): 975-9, 2014 Aug.
Artigo
em Japonês
| MEDLINE | ID: mdl-25132029
3.
Tissue Distribution of Cisplatin by Intra-arterial Infusion Route in Comparison to Systemic Route: Implication to Therapy for Node-positive Bladder Cancer.
In Vivo
; 37(1): 143-148, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36593015
4.
Prognostic impact of C-reactive protein-albumin ratio for the lethality in castration-resistant prostate cancer.
Med Oncol
; 37(1): 9, 2019 Nov 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31754918
5.
Comparison of Radiographic Progression-Free Survival and PSA Response on Sequential Treatment Using Abiraterone and Enzalutamide for Newly Diagnosed Castration-Resistant Prostate Cancer: A Propensity Score Matched Analysis from Multicenter Cohort.
J Clin Med
; 8(8)2019 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31430900
6.
The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma.
Oncotarget
; 8(66): 110311-110325, 2017 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29299149